Investment 123456
Trevi focuses primarily on venture and growth equity investments with emphasis on medical devices, biopharmaceuticals and healthcare services, either as a lead or co-investor. Trevi also invests, directly and with its strategic partners, in special situations, traditional buy-outs and structured finance transactions.
MEDICAL DEVICES
- FDA 510(k) regulatory route or PMA with proof-of-concept clinical data achieved
- "Disruptive" or enabling technologies that improve the safety and/or efficacy of current procedures or protocols
- Ability to use existing reimbursement codes or a strategy toward obtaining new codes and coverage
- Time to commercialization: up to three years
BIOPHARMACEUTICALS
- Lead candidate(s) with clinical data
- Specialty pharmaceutical emphasis—reformulation and/or new or expanded indications for existing therapeutics
- Development pipeline diversification: multiple compounds and/or indications
- Licensing opportunities, strategic collaborations or other catalysts that accelerate development and marketing processes
- Time to commercialization and/or substantial value inflection points: up to four years
HEALTHCARE SERVICES
- Stable or growing revenues prior to investment and present or near-term profitability
- Strong reimbursement strategy or unique niche focus
- Substantial opportunities to scale businesses
- Strong management track record